Desvenlafaxine



Indications and Reactions:

Role Indications Reactions
Primary
Depression 100.0%
Completed Suicide 33.3%
Pruritus 33.3%
Respiratory Arrest 33.3%
Secondary
Product Used For Unknown Indication 64.2%
Anxiety 5.2%
Drug Use For Unknown Indication 5.2%
Hypertension 4.7%
Overdose 4.7%
Depression 4.2%
Irritability 1.9%
Metastases To Lung 1.9%
Renal Cell Carcinoma 1.9%
Bipolar Disorder 0.9%
Neuropathy Peripheral 0.9%
Attention Deficit/hyperactivity Disorder 0.5%
Cataplexy 0.5%
Fibromyalgia 0.5%
Hallucination, Auditory 0.5%
Hypothyroidism 0.5%
Menopausal Symptoms 0.5%
Multiple Allergies 0.5%
Narcolepsy 0.5%
Obsessive-compulsive Disorder 0.5%
Completed Suicide 35.8%
Toxicity To Various Agents 9.4%
Overdose 5.7%
Respiratory Arrest 5.7%
Sinus Tachycardia 5.7%
Drug Hypersensitivity 3.8%
Poisoning 3.8%
Sedation 3.8%
Thyroid Function Test Abnormal 3.8%
Vascular Calcification 3.8%
Brain Injury 1.9%
Cardio-respiratory Arrest 1.9%
Disturbance In Attention 1.9%
Exposure Via Ingestion 1.9%
Hypokalaemia 1.9%
Intentional Overdose 1.9%
Myalgia 1.9%
Peritoneal Haemorrhage 1.9%
Somnambulism 1.9%
Somnolence 1.9%
Concomitant
Product Used For Unknown Indication 18.5%
Depression 18.1%
Cataplexy 5.6%
Hypertension 5.6%
Anxiety 5.1%
Breast Cancer 4.6%
Metastatic Malignant Melanoma 4.6%
Type 2 Diabetes Mellitus 4.6%
Cardiac Disorder 3.7%
Smoking Cessation Therapy 3.7%
Bipolar Disorder 2.8%
Bone Disorder 2.8%
Fibromyalgia 2.8%
Major Depression 2.8%
Prostate Cancer Metastatic 2.8%
Pulmonary Arterial Hypertension 2.8%
Somnolence 2.8%
Blood Cholesterol Increased 2.3%
Diabetes Mellitus 2.3%
Atrial Fibrillation 1.9%
Weight Decreased 13.6%
Nausea 9.1%
Tonsil Cancer 7.6%
Weight Increased 7.6%
Serotonin Syndrome 6.1%
Vomiting 6.1%
Depression 4.5%
Dyspnoea 4.5%
Off Label Use 4.5%
Schizophrenia 4.5%
Stress 4.5%
Clostridial Infection 3.0%
Completed Suicide 3.0%
Injection Site Swelling 3.0%
Muscle Contractions Involuntary 3.0%
Parasomnia 3.0%
Pneumonia 3.0%
Sleep Disorder 3.0%
Suicide Attempt 3.0%
Syncope 3.0%
Interacting
Product Used For Unknown Indication 50.0%
Antiplatelet Therapy 30.0%
Depression 20.0%
Drug Interaction 33.3%
Haematoma 33.3%
Spontaneous Haematoma 33.3%